Author details

Full Name

Tali Mazor

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37645893	Deconstructing intratumoral heterogeneity through multiomic and multiscale analysis of serial sections.	bioRxiv	2024
36634297	Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.	JCO Precis Oncol	2023
34587068	ThreadStates: State-based Visual Analysis of Disease Progression.	IEEE Trans Vis Comput Graph	2022
36202909	MatchMiner: an open-source platform for cancer precision medicine.	NPJ Precis Oncol	2022
36455195	Response to MEK Inhibitor Therapy in <i>MAP2K1</i> (<i>MEK1</i>) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of <i>MAP2K1</i> Mutations in Non-Small-Cell Lung Cancer.	JCO Precis Oncol	2022
33823014	Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.	Neuro Oncol	2021
33625877	OncoTree: A Cancer Classification System for Precision Oncology.	JCO Clin Cancer Inform	2021
33891899	Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease.	Dev Cell	2021
34252935	OncoThreads: visualization of large-scale longitudinal cancer molecular data.	Bioinformatics	2021
32904945	Patient-derived cells from recurrent tumors that model the evolution of <i>IDH</i>-mutant glioma.	Neurooncol Adv	2020
30877433	Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.	Acta Neuropathol	2019
31748746	Longitudinal molecular trajectories of diffuse glioma in adults.	Nature	2019
29077933	Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas.	Neuro Oncol	2018
29528181	Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.	Pediatr Blood Cancer	2018
27683180	Somatic and Germline <i>TP53</i> Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors.	Clin Cancer Res	2017
28916733	Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>.	Proc Natl Acad Sci U S A	2017
28759109	Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.	Cancer	2017
28319047	Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.	J Clin Invest	2017
29259179	Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.	Nat Commun	2017
27758882	Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.	Cancer Res	2016
27070699	Intratumoral Heterogeneity of the Epigenome.	Cancer Cell	2016
26711114	Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia.	Nat Genet	2016
26373278	DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.	Cancer Cell	2015
25724300	Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.	Acta Neuropathol	2015
26457647	The genomic landscape of juvenile myelomonocytic leukemia.	Nat Genet	2015
24336570	Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.	Science	2014
23293686	Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1.	J Huntingtons Dis	2012
22325351	Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors.	Mol Cell	2012
20442865	A quantitative model of transcriptional regulation reveals the influence of binding location on expression.	PLoS Computational Biology	2010
20876297	Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression.	Molecular and Cellular Biology	2010
17923406	N-Benzyl-3-sulfonamidopyrrolidines as novel inhibitors of cell division in E. coli.	Bioorganic and Medicinal Chemistry Letters	2007